{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "hmdb:HMDB06564",
      "entity_text" : "glucose",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-1092" ],
      "Organ" : [ "uberon:UBERON:0000104" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "All patients with type 1 or type 2 diabetes who experience nausea, vomiting, shortness of breath, or malaise in the setting of SGLT-2 inhibitor therapy should be promptly evaluated for urine and/or plasma ketones at home or in a medical setting, even if glucose levels are nearly normal.",
  "reading_complete" : "2020-07-28T12:59:20Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T12:57:50Z",
  "trigger" : "levels",
  "evidence" : [ "glucose levels" ],
  "pmc_id" : "4542270",
  "score" : 0
}